FABP4, another gene reported to be associated with SARIFA, was expressed 1.56 times higher in SARIFA-positive gastric cancers, but this difference did not reach statistical significance (p = 0.11, Wilcoxon test) (Figure 5). This evidence concerns the gene FABP4 and gastric cancer.